ATXS icon

Astria Therapeutics

20 hedge funds and large institutions have $129M invested in Astria Therapeutics in 2015 Q2 according to their latest regulatory filings, with 20 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
20
Holders Change
+20
Holders Change %
% of All Funds
0.54%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.05%
New
20
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SHI
1
SV Health Investors
Massachusetts
$34.9M 2,857,667 +2,857,667 New
CV
2
Clarus Ventures
Massachusetts
$33.6M 2,752,488 +2,752,488 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$17.8M 1,455,718 +1,455,718 New
CCM
4
Camber Capital Management
Massachusetts
$11.3M 927,609 +927,609 New
DM
5
Deerfield Management
New York
$9.01M 738,055 +738,055 New
SFM
6
Sphera Funds Management
Israel
$5.06M 446,036 +446,036 New
Wellington Management Group
7
Wellington Management Group
Massachusetts
$3.73M 305,137 +305,137 New
RPAM
8
Rhenman & Partners Asset Management
Sweden
$3.24M 265,427 +265,427 New
BI
9
BVF Inc
California
$2.75M 225,000 +225,000 New
PI
10
Putnam Investments
Massachusetts
$1.81M 148,131 +148,131 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$1.07M 88,000 +88,000 New
MIM
12
Monashee Investment Management
Massachusetts
Millennium Management
13
Millennium Management
New York
$913K 74,791 +74,791 New
Alyeska Investment Group
14
Alyeska Investment Group
Illinois
$611K 50,000 +50,000 New
Federated Hermes
15
Federated Hermes
Pennsylvania
$611K 50,000 +50,000 New
CC
16
Clearline Capital
New York
$571K 46,796 +46,796 New
Norges Bank
17
Norges Bank
Norway
$488K 40,000 +40,000 New
Goldman Sachs
18
Goldman Sachs
New York
$305K 25,000 +25,000 New
FAM
19
Fred Alger Management
New York
$244K 20,000 +20,000 New
Deutsche Bank
20
Deutsche Bank
Germany
$29K 2,400 +2,400 New
TRCT
21
Tower Research Capital (TRC)
New York
$8K 648 +648 New